Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
PUT
Accuray
ARAY
$34.1M
| $217K | ﹤0.01% |
45,600
+43,100
| +1,724% | +$225K |
|
4152
USA Compression Partners
USAC
$3.72B
| $217K | ﹤0.01% |
12,860
-5,990
| -32% | -$107K |
|
4153
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
| $217K | ﹤0.01% |
3,950
-2,720
| -41% | -$149K |
|
|
SJR
4154
DELISTED
Shaw Communications Inc.
SJR
| $217K | ﹤0.01% |
10,426
+8,003
| +330% | +$168K |
|
|
ARNA
4155
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $217K | ﹤0.01% |
14,855
+10,624
| +251% | +$157K |
|
|
4156
CALL
Accuray
ARAY
$34.1M
| $216K | ﹤0.01% |
45,400
+44,500
| +4,944% | +$232K |
|
4157
Orion Group Holdings
ORN
$437M
| $216K | ﹤0.01% |
28,892
+25,930
| +875% | +$245K |
|
4158
PUT
SAP
SAP
$226B
| $216K | ﹤0.01% |
2,200
-4,500
| -67% | -$418K |
|
|
GCP
4159
DELISTED
GCP Applied Technologies Inc.
GCP
| $216K | ﹤0.01% |
6,602
-2,373
| -26% | -$68.6K |
|
|
WSTC
4160
DELISTED
West Corporation
WSTC
| $216K | ﹤0.01% |
8,844
+4,952
| +127% | +$121K |
|
4161
EPAM Systems
EPAM
$5.79B
| $215K | ﹤0.01% |
2,842
+1,114
| +64% | +$77.5K |
|
|
HI
4162
DELISTED
Hillenbrand
HI
| $215K | ﹤0.01% |
5,989
+4,129
| +222% | +$152K |
|
|
PNNT
4163
Pennant Park Investment Corp
PNNT
$226M
| $215K | ﹤0.01% |
+26,363
| New | +$212K |
|
4164
Stoneridge
SRI
$209M
| $215K | ﹤0.01% |
11,922
+5,364
| +82% | +$94.4K |
|
|
LLL
4165
PUT
DELISTED
L3 Technologies, Inc.
LLL
| $215K | ﹤0.01% |
1,300
+900
| +225% | +$146K |
|
|
HEPA
4166
DELISTED
Hepion Pharmaceuticals
HEPA
| – | – |
0
| – | – |
|
4167
CALL
iShares Core S&P 500 ETF
IVV
$901B
| $214K | ﹤0.01% |
900
-10,100
| -92% | -$2.36M |
|
|
SHLD
4168
PUT
DELISTED
Sears Holding Corporation
SHLD
| $214K | ﹤0.01% |
18,600
-34,100
| -65% | -$285K |
|
4169
Merit Medical Systems
MMSI
$5.18B
| $213K | ﹤0.01% |
7,364
+5,897
| +402% | +$165K |
|
4170
New York Times
NYT
$10.3B
| $213K | ﹤0.01% |
14,783
-3,724
| -20% | -$53.2K |
|
4171
Surgery Partners
SGRY
$2.02B
| $213K | ﹤0.01% |
10,910
+10,235
| +1,516% | +$199K |
|
|
SPTN
4172
DELISTED
SpartanNash
SPTN
| $213K | ﹤0.01% |
6,118
-11,383
| -65% | -$417K |
|
4173
BlackRock TCP Capital
TCPC
$295M
| $213K | ﹤0.01% |
12,204
+12,151
| +22,926% | +$206K |
|
|
NM
4174
DELISTED
Navios Maritime Holdings Inc.
NM
| $213K | ﹤0.01% |
+11,400
| New | +$205K |
|
4175
CALL
Boston Properties
BXP
$11.2B
| $212K | ﹤0.01% |
1,600
-118,600
| -99% | -$15.7M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.